Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Serko Limited Director's Dealing 2020

Sep 28, 2020

66271_rns_2020-09-29_e2f33851-1863-48b3-8f09-9521bddb0bb9.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [69 x 21] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

)
N/A
N/A
The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any): N/A
A statement as to whether the derivative is cash settled or physicallysettled: N/A
Maturitydate of the derivative(if any): N/A
Expirydate of the derivative(if any): N/A
Theprice specified in the terms of the derivative(if any): N/A
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancial products: N/A
_For that derivative,- _Parties to the derivative:If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative:
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates: 1
Date of transaction: 18/09/2020 (Grant Date)
Nature of transaction: Grant of unlisted Restricted ShareUnits under Serko Long TermIncentive Scheme 2019
Name ofany otherparty orparties to the transaction(if known): N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into acash value, describe the consideration: Services to Serko Limited. Thereasonable present cash value of thenon-cash consideration is $4.40 perRestricted Share Unit.
Numberof financialproducts towhichthe transaction related: 27,273
If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period: N/A
Whether prior written clearance was provided to allow the acquisition or disposal toproceed duringthe closedperiod: N/A
Date of the prior written clearance(if any): N/A
Summary of other relevant interests after acquisition or disposal:Class of quoted financial products:Nature of relevantinterest:
Class of quoted financial products: Ordinary Shares in Serko Limited
Nature of relevantinterest: 1. Beneficial owner of RestrictedShares held on trust until vesting bySerko Trustee Limited2. Registered holder and beneficialownerofOrdinary Shares

For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:

  1. 32,872 Restricted Shares 2. 254,460 Ordinary Shares 1. Serko Trustee Limited for Susan Putt 2. Susan Putt N/A

Details of derivative,-

Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financialproducts (if any): N/A
A statement as to whether the derivative is cash settled or physically settled: N/A
Maturity date of the derivative (if any): N/A
Expiry date of the derivative (if any): N/A
The price's specified terms (if any): N/A
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: N/A
For that derivative relevant interest,- N/A
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: N/A

Certification

I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

Susan Putt (Sep 24, 2020 15:59 GMT+12)

Sep 24, 2020

==> picture [353 x 326] intentionally omitted <==